Why the study?
Does the addition of hydrochlorothiazide to captopril enhance antihypertensive activity in spontaneously hypertensive rats?
Does the addition of hydrochlorothiazide to captopril enhance antihypertensive activity in spontaneously hypertensive rats?
The potentiating effect of hydrochlorothiazide on captopril's antihypertensive activity is likely due to shifting the blood pressure maintenance system to a renin-dependent state rather than altering vascular reactivity.
Answers are grounded in this paper and cite their sources.
HCTZ may potentiate captopril in hypertensive rats; leaves open translation to human hypertension management.
Captopril (30 mg/kg/day orally for two days) in spontaneously hypertensive rats (SHR) inhibited serum angiotensin converting enzyme (ACE) activity 92.3%; increased plasma renin activity (PRA) 18-fold and reduced mean arterial blood pressure (MABP) 19 mm Hg. Hydrochlorothiazide (HCTZ) (100 mg/kg-day 1; 10 mg/kg-day 2, orally) increased PRA 3-fold but did not affect serum ACE or MABP. HCTZ plus captopril inhibited serum ACE 95.2%; increased PRA 38-fold and reduced MABP 47.5 mm Hg. Captopril or HCTZ plus captopril did not alter the responses of isolated aortic strips to norepinephrine (NE), serotonin, angiotensin II (AII) or isoproterenol. Pressor responses of conscious SHR to AII and NE were unaltered by captopril or HCTZ plus captopril although the bradykinin-induced depressor responses were significantly but equally potentiated. These results suggest that the potentiating effect of HCTZ is due to some mechanism that shifts the animal's blood pressure maintenance system to a renin-dependent state and is not due to changes in vascular reactivity.
No takes yet. Share an insight, caveat, or question.
Lai et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: